Hawking critiques EU stem cell decision

Jul 25, 2006

Renowned British scientist Stephen Hawking is criticizing a stem cell research funding ruling by the European Union as a "fudge."

Hawking's comments followed a compromise reached by the European Council during its Monday meeting in Brussels, The Guardian reported Tuesday. The council decided the EU will fund research into human embryonic stem cells.

However, the council ruled no EU money may be spent on projects in which human embryos are destroyed.

Hawking, a professor at the University of Cambridge, told educationguardian.co.uk, "I hope this fudge will place no practical limits on stem cell research. As I understand it, as long as the creation of new stem cell lines is paid for from private funds or national budgets, EU money can be spent on research using these lines.

"We throw away many embryos in IVF (in-vitro fertilization) and no one objects," he added. "Isn't it better to use a few embryos to save lives?"

Copyright 2006 by United Press International

Explore further: Pancreatic cancer risk not higher with diabetes Rx DPP-4i

add to favorites email to friend print save as pdf

Related Stories

Stem cells use 'first aid kits' to repair damage

Sep 18, 2014

Stem cells hold great promise as a means of repairing cells in conditions such as multiple sclerosis, stroke or injuries of the spinal cord because they have the ability to develop into almost any cell type. ...

Materials scientists turn to collagen

Jun 05, 2014

(Phys.org) —Miniature scaffolds made from collagen – the 'glue' that holds our bodies together – are being used to heal damaged joints, and could be used to develop new cancer therapies or help repair ...

National coordination needed to advance convergent research

May 07, 2014

Convergent research – which crosses disciplinary boundaries, integrating tools and knowledge from the life sciences, physical sciences, engineering, and other fields—could spur innovation and help tackle societal challenges, ...

Recommended for you

Pancreatic cancer risk not higher with diabetes Rx DPP-4i

55 minutes ago

(HealthDay)—There is no increased short-term pancreatic cancer risk with dipeptidyl-peptidase-4 inhibitors (DPP-4i) compared to sulfonylureas (SU) and thiazolidinediones (TZD) for glycemic control, according ...

Operative management of femoral neck Fx has changed

1 hour ago

(HealthDay)—Trends in operative management of femoral neck fractures by orthopedic surgeons applying for board certification have changed over time, according to research published in the Sept. 3 issue ...

User comments : 0